Growth • Icon
ICLR
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
24,2%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
23%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
16,2%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
7%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
9,9%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
25,5%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!